510(k) Report

510(k) · Cleared

Cleared

Synthes (Usa) Chronos

K043045510(k) TraditionalCleared Jan 7, 200564-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Synthes (Usa) · MQV Filler, Bone Void, Calcium Compound

Cleared on Jan 7, 2005 after a 64-day review. The FDA summary names its predicate without a number. 13 later devices descend from it.

Decided
Jan 7, 2005
Review
64 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
0

13 later devices descend from it, 5 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared2026: 2 descendants cleared2018: 1 descendant cleared2008: 1 descendant cleared2011: 1 descendant cleared2017: 1 descendant cleared2013: 1 descendant cleared2014: 1 descendant cleared2021: 1 descendant cleared2023: 1 descendant cleared2024: 1 descendant cleared2025: 1 descendant cleared20052010201520202025
  1. This deviceK043045 Synthes (Usa) ChronosSynthes (Usa) · 2005
  2. Descendant · cites it directly · 9 of its ownK071046 Synthes Chronos CompositeSynthes (Usa) · 2007
  3. Descendant · 2 generations on · 4 of its ownK171563 MagnetOs PuttyKuros Biosciences B.V · 2017
  4. Descendant · 3 generations on · 3 of its ownK211201 MagnetOs Easypack PuttyKuros Biosciences B.V · 2021
  5. Descendant · 4 generations on · 2 of its ownK233607 MagnetOs Easypack PuttyKuros Biosciences B.V · 2023
  6. Descendant · 5 generations on · 1 of its ownK241212 MagnetOs Easypack PuttyKuros Biosciences · 2024

Showing 5 of 13 descendants. See all descendants

Descendants cleared per year

2007: 12008: 12011: 12013: 12014: 12017: 12018: 12021: 12023: 12024: 12025: 12026: 2
2007high 2 (2026) · low 0 (2009)2026

Most influential descendants

Showing 5 of 13 · See all
  • K071046Synthes Chronos CompositeSynthes (Usa) · 2007 · cites it directly9descendants
  • K171563MagnetOs PuttyKuros Biosciences B.V · 2017 · 2 generations on4descendants
  • K211201MagnetOs Easypack PuttyKuros Biosciences B.V · 2021 · 3 generations on3descendants
  • K233607MagnetOs Easypack PuttyKuros Biosciences B.V · 2023 · 4 generations on2descendants
  • K241212MagnetOs Easypack PuttyKuros Biosciences · 2024 · 5 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K043045Synthes (Usa) ChronosSynthes (Usa)2005—
+1K071046Synthes Chronos CompositeSynthes (Usa)2007—
+2K171563MagnetOs PuttyKuros Biosciences B.V2017—
+3K211201MagnetOs Easypack PuttyKuros Biosciences B.V2021—
+4K233607MagnetOs Easypack PuttyKuros Biosciences B.V2023—
+5K241212MagnetOs Easypack PuttyKuros Biosciences2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200810
201110
201310
201410
201710
201810
202110
202310
202410
202510
202620
FIG. 1 — Lineage of K043045, 2005–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Synthes chronOS
Named without a submission number
—
*—Orthovita, Inc. Vitoss Scaffold Synthetic Cancellous Bone Void Filler
Named without a submission number
—
*—Imbibe II Syringe
Named without a submission number
—

What descends from it? (13)

See all 13

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K071046Synthes Chronos CompositeSynthes (Usa)20079
K252797JAZBI™ Resorbable Bone Void FillerSdip Innovations Pty, Ltd.20260
K253524Adaptos®Fuse Bone GraftBiomendex OY20260
K180758Osteocera Resorbable Bone SubstituteWiltrom Corporation Limited20180
K080065OsferionOlympus Terumo Biomaterials Corporation20080

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K071046 (Synthes (Usa), 2007) has gone furthest, with 9 descendants of its own.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

Synthes ebronOSTM is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony strueture. Synthes chronOSTM is indicated for use in the treatment of bony defects created surgically or through traumatic injury.

Synthes chronOS M is intended to be gently packed or placed into bony voids or gaps of the skeletal system (i.e. the extremities, spine, and pelvis) and may be combined with autogenous blood and/or bone marrow. Following placement into the bony void, chronOSTM resorb? and is replaced with bone during the healing process.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K043045: Synthes (Usa) Chronos.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K043045

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026